Wisnivesky, Juan P.
Govindarajulu, Usha
Bagiella, Emilia
Goswami, Ruchir
Kale, Minal
Campbell, Kirk N.
Meliambro, Kristin
Chen, Zijian
Aberg, Judith A.
Lin, Jenny J. http://orcid.org/0000-0001-7104-8480
Article History
Received: 4 November 2021
Accepted: 8 February 2022
First Online: 9 March 2022
Declarations
:
: Dr. Wisnivesky received consulting honorarium from Atea, Sanofi, PPD, and Banook and grants from Sanofi, Arnold Consulting, and Regeneron. Dr. Aberg reports grants from Atea, Emergent Biosolutions, Frontier Technologies, Gilead Sciences, Glaxo Smith Kline, Janssen, Merck, Pfizer, Regeneron, and Viiv Healthcare and consulting honorarium from Glaxo Smith Kline and Merck. The other authors report no conflicts of interest.
Free to read: This content has been made available to all.